Compare · HCA vs PACS
HCA vs PACS
Side-by-side comparison of HCA Healthcare Inc. (HCA) and PACS Group Inc. (PACS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HCA and PACS operate in Hospital/Nursing Management (Health Care), so they compete in similar markets.
- HCA is the larger of the two at $101.85B, about 14.3x PACS ($7.12B).
- Over the past year, HCA is up 11.6% and PACS is up 284.0% - PACS leads by 272.4 points.
- PACS has been more active in the news (8 items in the past 4 weeks vs 2 for HCA).
- HCA has more recent analyst coverage (25 ratings vs 6 for PACS).
- Company
- HCA Healthcare Inc.
- PACS Group Inc.
- Price
- $468.49-0.42%
- $47.81+6.48%
- Market cap
- $101.85B
- $7.12B
- 1M return
- +8.85%
- +11.81%
- 1Y return
- +11.62%
- +284.02%
- Industry
- Hospital/Nursing Management
- Hospital/Nursing Management
- Exchange
- NYSE
- NYSE
- IPO
- 2011
- 2024
- News (4w)
- 2
- 8
- Recent ratings
- 25
- 6
HCA Healthcare Inc.
HCA Healthcare, Inc., through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling. In addition, the company operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. As of December 31, 2020, it operated 185 hospitals, which included 178 general, acute care hospitals, as well as five psychiatric hospitals and two rehabilitation hospitals; 121 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Latest HCA
- HCA Healthcare, Inc. 3rd Quarter 2026 Earnings Conference Call
- BMO Capital Markets initiated coverage on HCA with a new price target
- HCA Healthcare Completes Acquisition of the College of Health Care Professions
- New insider Schlosser Michael J claimed ownership of 7,121 shares (SEC Form 3)
- EVP & Chief Legal & Admin Off. Mcalevey Michael R disposed of $3,332,901 worth of shares (7,769 units at $429.00) (SEC Form 4)
- HCA Healthcare, Inc. to Present at September Conferences
- HCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group
- HCA Healthcare Inc. filed SEC Form 8-K: Other Events, Creation of a Direct Financial Obligation
- SEC Form 10-Q filed by HCA Healthcare Inc.
- HCA Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Latest PACS
- SEC Form 144 filed by PACS Group Inc.
- SEC Form 4 filed by PACS Group Inc.
- SEC Form 4 filed by PACS Group Inc.
- Omega to Transition Operations of 32 Facilities in Florida to PACS Group
- Seventeen PACS Post-Acute Locations Named Top Nursing Homes for 2027 by Newsweek Magazine
- SEC Form 3 filed by new insider Murphy Patrick (Joseph)
- PACS Group Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- PACS Group Announces Chief Legal Officer Transition
- President & COO Jergensen Joshua sold $1,725,133 worth of shares (40,000 units at $43.13) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 2,496,320 units (SEC Form 4)
- Director Hancock Mark sold $13,044,882 worth of shares (300,000 units at $43.48) as part of a pre-agreed trading plan, decreasing direct ownership by 0.56% to 53,518,884 units (SEC Form 4)